Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.
Christopher J
CJ
Boos
Gregory Y H
GY
Lip
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000517:prevention & control*; D015415:Biomarkers / Q000032:analysis; D002097:C-Reactive Protein / Q000032:analysis*; D006801:Humans; D011945:Receptors, Angiotensin / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D011945:Receptors, Angiotensin; D002097:C-Reactive Protein